What is the EV/FCF ratio for NeoGenomics, Inc. (NEO)?

The EV/FCF ratio for NEO stock is N/A.

What is the estimated TTM average EV/FCF ratio for NeoGenomics, Inc. (NEO)?

The estimated TTM average EV/FCF ratio for NEO stock is 29.10x.

What is the estimated 3Y average EV/FCF ratio for NeoGenomics, Inc. (NEO)?

The estimated 3Y average EV/FCF ratio for NEO stock is 38.67x.

What is the estimated 5Y average EV/FCF ratio for NeoGenomics, Inc. (NEO)?

The estimated 5Y average EV/FCF ratio for NEO stock is 20.59x.

NeoGenomics (NEO) EV/FCF: History & Chart

Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/FCF ratio is N/A as of 2026-10-02T19:05:52.185Z.

Stored calculation inputs

Calculation as of: 2026-10-02T19:05:52.185Z.

Quote observation: 2026-10-02T19:05:12.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 470,346,975
Total debt · period ending 2026-06-30: 448,368,000
Cash · period ending 2026-06-30: 145,539,000
TTM free cash flow · period ending 2026-06-30: -7,355,000

FMP input reference: dd069712ede8f4b2ce64df8e3e19fb9c01fcfd31feb2761ca66e255950af83c7

Free Cash Flow|FCF Yield|P/FCF Ratio|EV/EBITDA|All Metrics

NEO EV/FCF Ratio Metrics

EV/FCF RATIO

N/A

EV/FCF RATIO AVG TTM

29.10x

EV/FCF RATIO AVG 3Y

38.67x

EV/FCF RATIO AVG 5Y

20.59x

EV/FCF RATIO AVG 10Y

N/A

EV/FCF RATIO AVG 15Y

N/A

EV/FCF RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

NEO Competitors' EV/FCF Ratio

NEO

NeoGenomics, Inc.

Current

Market Cap

$470.35M

EV/FCF Ratio

N/A

TTM Avg

29.10x

3Y Avg

38.67x

5Y Avg

20.59x

NRC

NRC Health

vs NEO

Market Cap

$459.30M

EV/FCF Ratio

25.23x

TTM Avg

33.00x

3Y Avg

32.11x

5Y Avg

32.13x

SI

Shoulder Innovations, Inc.

vs NEO

Market Cap

$389.98M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PDSB

PDS Biotechnology Corporation

vs NEO

Market Cap

$41.24M

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

TDOC

Teladoc Health, Inc.

vs NEO

Market Cap

$1.01B

EV/FCF Ratio

5.64x

TTM Avg

6.84x

3Y Avg

8.42x

5Y Avg

16.00x

NTLA

Intellia Therapeutics, Inc.

vs NEO

Market Cap

$1.71B

EV/FCF Ratio

N/A

TTM Avg

6.04x

3Y Avg

6.04x

5Y Avg

6.04x

XRAY

DENTSPLY SIRONA Inc.

vs NEO

Market Cap

$1.74B

EV/FCF Ratio

26.63x

TTM Avg

43.79x

3Y Avg

32.56x

5Y Avg

29.02x

RXRX

Recursion Pharmaceuticals, Inc.

vs NEO

Market Cap

$2.13B

EV/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BEAM

Beam Therapeutics Inc.

vs NEO

Market Cap

$2.49B

EV/FCF Ratio

N/A

TTM Avg

44.45x

3Y Avg

44.45x

5Y Avg

44.45x

TMDX

TransMedics Group, Inc.

vs NEO

Market Cap

$2.72B

EV/FCF Ratio

39.39x

TTM Avg

57.66x

3Y Avg

90.43x

5Y Avg

90.43x

NAME	MARKET CAP	EV/FCF RATIO	TTM	3Y	5Y
NeoGenomics, Inc. (NEO)	$470.35M	N/A	29.10x	38.67x	20.59x
NRC Health (NRC)vs ›	$459.30M	25.23x	33.00x	32.11x	32.13x
Shoulder Innovations, Inc. (SI)vs ›	$389.98M	N/A	N/A	N/A	N/A
PDS Biotechnology Corporation (PDSB)vs ›	$41.24M	N/A	N/A	N/A	N/A
Teladoc Health, Inc. (TDOC)vs ›	$1.01B	5.64x	6.84x	8.42x	16.00x
Intellia Therapeutics, Inc. (NTLA)vs ›	$1.71B	N/A	6.04x	6.04x	6.04x
DENTSPLY SIRONA Inc. (XRAY)vs ›	$1.74B	26.63x	43.79x	32.56x	29.02x
Recursion Pharmaceuticals, Inc. (RXRX)vs ›	$2.13B	N/A	N/A	N/A	N/A
Beam Therapeutics Inc. (BEAM)vs ›	$2.49B	N/A	44.45x	44.45x	44.45x
TransMedics Group, Inc. (TMDX)vs ›	$2.72B	39.39x	57.66x	90.43x	90.43x

Cash Flow Valuation Comparison

EV/FCF

N/A

P/FCF

N/A

FCF Yield

N/A

Formula: EV/FCF = Enterprise Value / Free Cash Flow

EV/FCF vs P/FCF:

EV/FCF accounts for debt and cash through enterprise value
P/FCF only considers equity value
EV/FCF can be compared across companies with different debt levels
Both measure how the market values cash generation

EV/FCF Ratio Formula & Definition

EV/FCF = Enterprise Value / Free Cash Flow (TTM)

Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/FCF Ratio FAQ

What is the EV/FCF ratio for NeoGenomics, Inc. (NEO)?: The EV/FCF ratio for NEO stock is N/A.
What is the estimated TTM average EV/FCF ratio for NeoGenomics, Inc. (NEO)?: The estimated TTM average EV/FCF ratio for NEO stock is 29.10x.
What is the estimated 3Y average EV/FCF ratio for NeoGenomics, Inc. (NEO)?: The estimated 3Y average EV/FCF ratio for NEO stock is 38.67x.
What is the estimated 5Y average EV/FCF ratio for NeoGenomics, Inc. (NEO)?: The estimated 5Y average EV/FCF ratio for NEO stock is 20.59x.

NEO EV/FCF Ratio History

DATE	EV/FCF RATIO
2020-04-29	186.62x
2020-04-28	166.93x
2020-04-27	181.84x
2020-04-24	178.29x
2020-04-23	169.13x
2020-04-22	164.99x
2020-04-21	163.38x
2020-04-20	170.87x
2020-04-17	175.19x
2020-04-16	168.29x
2020-04-15	164.35x
2020-04-14	171.97x
2020-04-13	164.35x
2020-04-09	161.38x
2020-04-08	155.63x
2020-04-07	147.43x
2020-04-06	155.50x
2020-04-03	142.66x
2020-04-02	160.86x
2020-04-01	156.02x
2020-03-31	164.61x
2020-03-30	165.25x
2020-03-27	152.34x
2020-03-26	162.28x
2020-03-25	156.60x
2020-03-24	160.99x
2020-03-23	142.53x
2020-03-20	150.79x
2020-03-19	158.86x
2020-03-18	147.11x
2020-03-17	141.62x
2020-03-16	118.70x
2020-03-13	151.89x
2020-03-12	140.91x
2020-03-11	146.34x
2020-03-10	167.45x
2020-03-09	163.06x
2020-03-06	174.16x
2020-03-05	183.65x
2020-03-04	188.11x
2020-03-03	179.65x
2020-03-02	176.68x
2020-02-28	31.10x
2020-02-27	30.13x
2020-02-26	33.05x
2020-02-25	32.43x
2020-02-24	33.40x
2020-02-21	36.00x
2020-02-20	36.72x
2020-02-19	38.33x
2020-02-18	37.88x
2020-02-14	38.00x
2020-02-13	38.02x
2020-02-12	38.40x
2020-02-11	37.12x
2020-02-10	35.57x
2020-02-07	34.45x
2020-02-06	34.72x
2020-02-05	34.60x
2020-02-04	36.05x
2020-02-03	35.70x
2020-01-31	35.70x
2020-01-30	36.83x
2020-01-29	36.78x
2020-01-28	37.52x
2020-01-27	36.26x
2020-01-24	35.78x
2020-01-23	36.59x
2020-01-22	36.59x
2020-01-21	35.87x
2020-01-17	35.48x
2020-01-16	36.13x
2020-01-15	35.89x
2020-01-14	35.71x
2020-01-13	35.16x
2020-01-10	33.19x
2020-01-09	32.65x
2020-01-08	32.16x
2020-01-07	32.17x
2020-01-06	32.32x
2020-01-03	32.25x
2020-01-02	31.94x
2019-12-31	32.18x
2019-12-30	32.02x
2019-12-27	32.77x
2019-12-26	32.55x
2019-12-24	32.88x
2019-12-23	32.88x
2019-12-20	31.40x
2019-12-19	30.42x
2019-12-18	31.17x
2019-12-17	29.15x
2019-12-16	29.28x
2019-12-13	28.84x
2019-12-12	29.08x
2019-12-11	28.64x
2019-12-10	28.85x
2019-12-09	28.31x
2019-12-06	29.08x
2019-12-05	28.43x
2019-12-04	28.29x
2019-12-03	27.84x
2019-12-02	28.00x
2019-11-29	28.12x
2019-11-27	28.11x
2019-11-26	28.37x
2019-11-25	27.98x
2019-11-22	26.48x
2019-11-21	26.61x
2019-11-20	26.48x
2019-11-19	26.25x
2019-11-18	26.28x
2019-11-15	26.07x
2019-11-14	25.37x
2019-11-13	34.07x
2019-11-12	33.69x
2019-11-11	33.22x
2019-11-08	32.90x
2019-11-07	31.84x
2019-11-06	32.83x
2019-11-05	34.14x
2019-11-04	34.00x
2019-11-01	32.87x
2019-10-31	33.27x
2019-10-30	33.72x
2019-10-29	33.93x
2019-10-28	30.06x
2019-10-25	28.65x
2019-10-24	28.65x
2019-10-23	28.29x
2019-10-22	28.65x
2019-10-21	29.24x
2019-10-18	29.11x
2019-10-17	29.39x
2019-10-16	29.05x
2019-10-15	29.11x
2019-10-14	28.26x
2019-10-11	28.31x
2019-10-10	28.18x
2019-10-09	27.98x
2019-10-08	28.80x
2019-10-07	29.10x
2019-10-04	28.59x
2019-10-03	27.43x
2019-10-02	27.77x
2019-10-01	27.12x
2019-09-30	27.36x
2019-09-27	27.36x
2019-09-26	28.20x
2019-09-25	28.56x
2019-09-24	29.69x
2019-09-23	31.16x
2019-09-20	31.58x
2019-09-19	31.50x
2019-09-18	31.38x
2019-09-17	30.96x
2019-09-16	31.25x
2019-09-13	30.84x
2019-09-12	32.68x
2019-09-11	32.14x
2019-09-10	31.32x
2019-09-09	33.07x
2019-09-06	35.98x
2019-09-05	35.86x
2019-09-04	35.83x
2019-09-03	35.17x
2019-08-30	36.45x
2019-08-29	36.15x
2019-08-28	35.56x
2019-08-27	36.12x
2019-08-26	36.31x
2019-08-23	35.58x
2019-08-22	37.70x
2019-08-21	38.40x
2019-08-20	37.22x
2019-08-19	37.27x
2019-08-16	36.85x
2019-08-15	35.76x
2019-08-14	35.81x
2019-08-13	37.33x
2019-08-12	36.34x
2019-08-09	37.69x
2019-08-08	37.87x
2019-08-07	25.72x
2019-08-06	24.72x
2019-08-05	23.81x
2019-08-02	25.26x
2019-08-01	25.60x
2019-07-31	24.42x
2019-07-30	24.04x
2019-07-29	24.36x
2019-07-26	23.70x
2019-07-25	23.37x
2019-07-24	23.69x
2019-07-23	23.51x
2019-07-22	23.49x
2019-07-19	24.00x
2019-07-18	23.74x
2019-07-17	24.04x
2019-07-16	23.49x
2019-07-15	22.80x
2019-07-12	22.62x
2019-07-11	23.20x
2019-07-10	23.23x
2019-07-09	23.42x
2019-07-08	23.04x
2019-07-05	23.55x
2019-07-03	23.36x
2019-07-02	23.00x
2019-07-01	22.89x
2019-06-28	22.48x
2019-06-27	22.16x
2019-06-26	21.85x
2019-06-25	22.99x
2019-06-24	23.40x
2019-06-21	23.61x
2019-06-20	24.05x
2019-06-19	24.08x
2019-06-18	23.92x
2019-06-17	24.20x
2019-06-14	23.40x
2019-06-13	23.33x
2019-06-12	23.21x
2019-06-11	22.73x
2019-06-10	23.66x
2019-06-07	23.58x
2019-06-06	23.07x
2019-06-05	22.94x
2019-06-04	22.94x
2019-06-03	22.35x
2019-05-31	22.29x
2019-05-30	22.05x
2019-05-29	21.89x
2019-05-28	22.05x
2019-05-24	21.93x
2019-05-23	21.82x
2019-05-22	22.37x
2019-05-21	22.40x
2019-05-20	23.48x
2019-05-17	23.32x
2019-05-16	23.78x
2019-05-15	23.41x
2019-05-14	23.26x
2019-05-13	22.70x
2019-05-10	23.24x
2019-05-09	22.57x
2019-05-08	17.51x
2019-05-07	17.60x
2019-05-06	18.35x
2019-05-03	18.14x
2019-05-02	17.66x
2019-05-01	17.03x
2019-04-30	16.61x
2019-04-29	16.64x
2019-04-26	16.38x
2019-04-25	16.24x
2019-04-24	16.07x
2019-04-23	16.19x
2019-04-22	16.07x
2019-04-18	15.86x

Showing the most recent 260 of 1,553 data points. The chart above shows the full history.

EV/FCF Ratio: N/A

NEO EV/FCF Ratio Chart

NEO Average EV/FCF Ratio Chart

NEO EV/FCF Ratio Metrics

NEO Competitors' EV/FCF Ratio

Cash Flow Valuation Comparison

EV/FCF Ratio Formula & Definition

EV/FCF Ratio FAQ

NEO EV/FCF Ratio History

Related Metrics